FDA Approves Heplisav-B, the First Two-Dose Hepatitis B Vaccine

Like
Like Love Haha Wow Sad Angry

FDA Approves Heplisav-B, the First Two-Dose Hepatitis B Vaccine Heplisav-B, the only 2-dose Hepatitis B (HBV) vaccine recombinant in the United States, has now been approved by the US Food and Drug Administration (FDA) for the prevention of infection caused by all known subtypes of HBV. Hepatitis B is an extremely infectious and potentially deadly […]

The post FDA Approves Heplisav-B, the First Two-Dose Hepatitis B Vaccine appeared first on BioTecNika .Read more at www.biotecnika.org/2018/05/fda-approves-heplisav-b-the-first-two-dose-hepatitis-b-vaccine/

Like
Like Love Haha Wow Sad Angry

Related posts